Dorsey Wright & Associates Kal Vista Pharmaceuticals, Inc. Transaction History

Dorsey Wright & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$14.69 - $42.57 $10,283 - $29,799	-700 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$12.88 - $19.47 $9,016 - $13,629	700 New	700 $13,000
Q2 2019 Jul 02, 2019	SELL	$18.44 - $30.89 $7,984 - $13,375	-433 Closed	0 $0
Q1 2019 Apr 04, 2019	SELL	$16.51 - $31.1 $7,082 - $13,341	-429 Reduced 49.77%	433 $12,000
Q4 2018 Jan 07, 2019	BUY	$16.21 - $24.06 $13,973 - $20,739	862 New	862 $17,000

129

46.5M

113K

72K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $290M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.